Tehran University of Medical Sciences

Science Communicator Platform

Share By
A Comprehensive Review of Mrna-Based Vaccines for Covid-19, a New Era in Pharmaceuticals: Unspecified and Unknown Aspects, Effects and Challenges Publisher Pubmed



P Vosoughi PEGAH ; Sm Naghib Seyed MORTEZA ; M Rahmanian MEHDI ; Mr Mozafari M R
Authors

Source: Current Topics in Medicinal Chemistry Published:2025


Abstract

Ongoing research and development efforts are currently focused on creating COVID-19 vaccines using a variety of platforms. Among these, mRNA technology stands out as a cutting-edge method for vaccine development. There is a growing public awareness of mRNA and its potential in vaccine development. Despite being relatively recent, extensive scientific research has been dedicated to vaccines for a considerable period. mRNA vaccines are created by synthesizing the spike protein from a DNA template. This review delves into the various aspects of these vaccines and thoroughly explores the intricacies of COVID-19 vaccinations. It is essential to choose a reliable, efficient, and widely accessible vaccine to combat COVID-19. However, due to the possibility of virus mutations, developing a dependable and safe vaccine is crucial to prepare for future outbreaks of SARS-CoV-2 variants. Meanwhile, concerns remain regarding the potential risks associated with these vaccines. © 2025 Elsevier B.V., All rights reserved.
1. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
Experts (# of related papers)
Other Related Docs
4. Influenza Vaccine: Where Are We and Where Do We Go?, Reviews in Medical Virology (2019)
8. Review on Approved and Inprogress Covid-19 Vaccines, Iranian Journal of Pharmaceutical Research (2022)
13. Computer-Assisted Multi-Epitopes T-Cell Subunit Covid-19 Vaccine Design, Biomedical and Biotechnology Research Journal (2021)
15. D D a Strategies to Designing Chimeric Recombinant Vaccines, Journal of Applied Biotechnology Reports (2021)
17. Design of a Multi-Epitope Vaccine Against Sars-Cov-2 Using Immunoinformatics Approach, International Journal of Biological Macromolecules (2020)